A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

NCT01185340 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1056

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: LY2216684
DRUG: Placebo
DRUG: SSRI

Sponsor

Eli Lilly and Company